Expression of von Willebrand's factor, CD34, CD31, and vascular endothelial growth factor in uterine leiomyomas

被引:32
作者
Poncelet, C [1 ]
Madelenat, P [1 ]
Feldmann, G [1 ]
Walker, F [1 ]
Darai, E [1 ]
机构
[1] INSERM, U327, F-75870 Paris 18, France
关键词
angiogenesis; FvW; CD34; CD31; vascular endothelial growth factor; myometrium; leiomyoma;
D O I
10.1016/S0015-0282(02)03301-0
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To compare the vascular parameters of uterine leiomyomas and normal myometrium, to correlate these parameters with vascular endothelial growth factor (VEGF) expression and clinical/pathological parameters, and to compare vascular parameters according to the endothelial markers used. Design: An immunohistochemical technique was applied to formalin-fixed paraffin-embedded tissue samples, using antibodies against von Willebrand's factor (FvW), CD34, CD31, and VEGF. The intratumoral vascular area (VA), microvessel density (MVD), and vascular luminal area (VLA) were determined with an image analyser. Setting: University teaching hospital. Patient(s): Thirty-two patients with uterine leiomyomas underwent conservative surgery. Twenty leiomyoma-free patients undergoing hysterectomy were the controls. Intervention(s): Immunohistochemical and morphometrical analysis. Main Outcome Measure(s): Measurements of VA, MVD, and VLA. Result(s): The CD34 labeling showed decreased VA in myomas compared with myometrium. Decreased MVD and an increased VLA in myomas were found with FvW and CD34 labeling. The VA, MVD, and VLA were not related to VEGF expression or to clinical/pathological parameters. Similar results for VA and MVD were obtained with FvW and CD34 labeling. Conclusion(s): Leiomyomas have a smaller vascular area, a lower microvessel density, and a higher vascular luminal area than normal myometrium. (C) 2002 by American Society for Reproductive Medicine.
引用
收藏
页码:581 / 586
页数:6
相关论文
共 39 条
  • [1] Effect of gonadotropin-releasing hormone agonist treatment upon angiogenesis in uterine leiomyoma
    Abulafia, O
    Kleinhaus, K
    Levi, G
    Lee, YC
    Sherer, DM
    [J]. GYNECOLOGIC AND OBSTETRIC INVESTIGATION, 2001, 52 (02) : 108 - 113
  • [2] Angiogenesis in malignancies of the female genital tract
    Abulafia, O
    Triest, WE
    Sherer, DM
    [J]. GYNECOLOGIC ONCOLOGY, 1999, 72 (02) : 220 - 231
  • [3] Andersen J, 1998, BAILLIERE CLIN OB GY, V12, P225
  • [4] Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis
    Bergers, G
    Brekken, R
    McMahon, G
    Vu, TH
    Itoh, T
    Tamaki, K
    Tanzawa, K
    Thorpe, P
    Itohara, S
    Werb, Z
    Hanahan, D
    [J]. NATURE CELL BIOLOGY, 2000, 2 (10) : 737 - 744
  • [5] Clinical significance of cytogenetic abnormalities in uterine myomas
    Brosens, I
    Deprest, J
    Dal Cin, P
    Van den Bergh, H
    [J]. FERTILITY AND STERILITY, 1998, 69 (02) : 232 - 235
  • [6] BUTTRAM VC, 1981, FERTIL STERIL, V36, P433
  • [7] Role of HIF-1α or in hypoxia-mediated apoptosis, cell proliferation and tumour angiogenesis
    Carmeliet, P
    Dor, Y
    Herbert, JM
    Fukumura, D
    Brusselmans, K
    Dewerchin, M
    Neeman, M
    Bono, F
    Abramovitch, R
    Maxwell, P
    Koch, CJ
    Ratcliffe, P
    Moons, L
    Jain, RK
    Collen, D
    Keshet, E
    [J]. NATURE, 1998, 394 (6692) : 485 - 490
  • [8] An immunohistochemical analysis of fibroid vasculature
    Casey, R
    Rogers, PAW
    Vollenhoven, BJ
    [J]. HUMAN REPRODUCTION, 2000, 15 (07) : 1469 - 1475
  • [9] Uterine leiomyosarcoma has deregulated cell proliferation, but not increased microvessel density compared with uterine leiomyoma
    Chou, CY
    Huang, SC
    Tsai, YC
    Hsu, KF
    Huang, KE
    [J]. GYNECOLOGIC ONCOLOGY, 1997, 65 (02) : 225 - 231
  • [10] VASCULAR ENDOTHELIAL GROWTH-FACTOR AND ITS RECEPTORS, FLT-1 AND FLK-1, ARE EXPRESSED IN NORMAL PANCREATIC-ISLETS AND THROUGHOUT ISLET-CELL TUMORIGENESIS
    CHRISTOFORI, G
    NAIK, P
    HANAHAN, D
    [J]. MOLECULAR ENDOCRINOLOGY, 1995, 9 (12) : 1760 - 1770